[HTML][HTML] Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
C Fu, L Yu, Y Miao, X Liu, Z Yu, M Wei - Acta Pharmaceutica Sinica B, 2023 - Elsevier
Peptide–drug conjugates (PDCs) are the next generation of targeted therapeutics drug after
antibody–drug conjugates (ADCs), with the core benefits of enhanced cellular permeability …
antibody–drug conjugates (ADCs), with the core benefits of enhanced cellular permeability …
Prostate cancer theranostics targeting gastrin-releasing peptide receptors
Gastrin-releasing peptide receptors (GRPRs), part of the bombesin (BBN) family, are
aberrantly overexpressed in many cancers, including those of the breast, prostate, pancreas …
aberrantly overexpressed in many cancers, including those of the breast, prostate, pancreas …